CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-07 | ARMISTICE CAPITAL, LLC Director | Sale | −100,000 | $2.51 | $251K | 15,800,000 |
| 2020-05-07 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 15,800,000 | ||
| 2020-05-06 | ARMISTICE CAPITAL, LLC Director | Sale | −50,000 | $2.58 | $129K | 15,900,000 |
| 2020-05-06 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 15,900,000 | ||
| 2020-05-05 | ARMISTICE CAPITAL, LLC Director | Sale | −692,531 | $2.66 | $1.8M | 15,950,000 |
| 2020-05-05 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 15,950,000 | ||
| 2020-05-04 | ARMISTICE CAPITAL, LLC Director | Sale | −957,469 | $2.65 | $2.5M | 16,642,531 |
| 2020-05-04 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 16,642,531 | ||
| 2020-05-01 | ARMISTICE CAPITAL, LLC Director | Sale | −1,000,000 | $2.71 | $2.7M | 17,600,000 |
| 2020-05-01 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 17,600,000 | ||
| 2020-04-30 | ARMISTICE CAPITAL, LLC Director | Sale | −4,434,296 | $2.96 | $13.1M | 18,600,000 |
| 2020-04-30 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 18,600,000 | ||
| 2020-04-29 | ARMISTICE CAPITAL, LLC Director | Sale | −873,634 | $3.01 | $2.6M | 23,034,296 |
| 2020-04-29 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 23,034,296 | ||
| 2020-04-28 | Davis Todd C Director | Sale | −60,000 | $3.28 | $197K | 120,000 |
| 2020-04-28 | ARMISTICE CAPITAL, LLC Director | Sale | −1,292,070 | $3.38 | $4.4M | 23,907,930 |
| 2020-04-28 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 23,907,930 | ||
| 2019-11-18 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +54,720 | 54,720 | ||
| 2019-11-18 | Yedid Robert A. Director | Grant or award · Stock Option (right to buy) | +54,720 | 54,720 | ||
| 2019-11-18 | Yedid Robert A. Director | Grant or award · Stock Option (right to buy) | +54,720 | 54,720 |
Page 17 of 23 · 442 trades